Sequential rituximab therapy sustains remission of nephrotic syndrome but carries high risk of adverse effectsAditi Sinha, Arvind Bagga, Kshetrimayum Ghanapriya et al.|Nephrology Dialysis Transplantation|2022Cited by 32
Efficacy of rituximab versus tacrolimus in difficult-to-treat steroid-sensitive nephrotic syndrome: an open-label pilot randomized controlled trialGeorgie Mathew, Arvind Bagga, Aditi Sinha et al.|Pediatric Nephrology|2022Cited by 21